SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001847903-24-000081
Filing Date
2024-05-13
Accepted
2024-05-13 16:32:10
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnta-20240331.htm   iXBRL 10-Q 1385770
2 EX-31.1 a20240331exhibit311.htm EX-31.1 9297
3 EX-31.2 a20240331exhibit312.htm EX-31.2 9226
4 EX-32.1 a20240331exhibit321.htm EX-32.1 5247
5 EX-32.2 a20240331exhibit322.htm EX-32.2 5061
  Complete submission text file 0001847903-24-000081.txt   6023349

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20240331.xsd EX-101.SCH 38232
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnta-20240331_cal.xml EX-101.CAL 62841
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20240331_def.xml EX-101.DEF 201966
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20240331_lab.xml EX-101.LAB 577387
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20240331_pre.xml EX-101.PRE 396177
70 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20240331_htm.xml XML 590278
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40445 | Film No.: 24939624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)